Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4091K | ISIN: US6294442099 | Ticker-Symbol: B1Q
Frankfurt
06.06.25 | 20:11
2,820 Euro
+12,80 % +0,320
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
NRX PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
NRX PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur NRX PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoNew to The Street Signs National Media Agreement with NRx Pharmaceuticals for 12-Part Broadcast Series Across TV, Digital, and Outdoor Platforms230NEW YORK CITY, NEW YORK / ACCESS Newswire / June 5, 2025 / New to The Street, the nation's leading multi-platform financial news show, today announced it has signed a 12-part media partnership with...
► Artikel lesen
DoNRx Pharma Submits ANDA For Preservative-free IV Ketamine4
DoNRx Pharmaceuticals files for preservative-free ketamine1
DoNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine43Ketamine faces a current US drug shortage not expected to abate in the near future1 Current ketamine market estimated at $750 million and projected to reach $3.35...
► Artikel lesen
28.05.NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic Network3
21.05.NRX Pharmaceuticals, Inc. - 8-K, Current Report2
15.05.NRX Pharmaceuticals, Inc. - 10-Q, Quarterly Report4
15.05.NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update108Company has continued to advance its previously announced plan to obtain FDA approval for two new drugs and to develop a network of clinics focused on neuroplastic therapies to treat...
► Artikel lesen
NRX PHARMACEUTICALS Aktie jetzt für 0€ handeln
15.05.HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions84Term sheet with Universal Capital, LLC to fund HOPE Therapeutics clinic acquisition strategy Funding tied to already-announced acquisitions, with additional tranches contemplated for...
► Artikel lesen
14.05.Uncovering Potential: NRX Pharmaceuticals' Earnings Preview2
13.05.HOPE Therapeutics and NRx Pharmaceuticals to buy Kadima Institute3
13.05.NRX Pharmaceuticals, Inc. - 8-K, Current Report1
13.05.HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute152Kadima Neuropsychiatry Institute in La Jolla, CA expected to serve as clinical model for Hope treatment offerings nationwide Kadima is a leading investigative site for CNS and psychedelic...
► Artikel lesen
05.05.NRx Pharmaceuticals beantragt Patent für konservierungsmittelfreies Ketamin3
05.05.NRx Pharmaceuticals seeks patent for preservative-free ketamine1
05.05.NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV Ketamine73Patent expected to be Orange Book listable, if granted NRX-100, preservative free, IV ketamine, is designed to avoid potential toxicity concerns linked to benzethonium chloride, used...
► Artikel lesen
30.04.NRX Pharmaceuticals, Inc. - 10-K/A, Annual Report1
30.04.NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression75Waiver exempts NRx from paying a $4.3 million New Drug Application filing fee under the Prescription Drug User Fee Act (PDUFA) Company is on track for Q2 2025...
► Artikel lesen
17.04.NRX Pharmaceuticals, Inc. - 8-K, Current Report3
03.04.HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE99Investment to support initiation of HOPE's network of clinics to treat suicidal depression and PTSD with ketamine, TMS and other modalities MIAMI, April 3, 2025 /PRNewswire/ --...
► Artikel lesen
Weiter >>
54 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1